Junichi Enokizono

803 total citations
20 papers, 667 citations indexed

About

Junichi Enokizono is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Junichi Enokizono has authored 20 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Junichi Enokizono's work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Junichi Enokizono is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Junichi Enokizono collaborates with scholars based in Japan, France and United Kingdom. Junichi Enokizono's co-authors include Yuichi Sugiyama, Hiroyuki Kusuhara, Alfred H. Schinkel, Atsushi Ose, Eri Taguchi, Daisuke Shinmi, Yoji Arata, Koichi Kato, Ichio Shimada and Kazuhiro Masuda and has published in prestigious journals such as Journal of Molecular Biology, Journal of Bacteriology and Journal of Controlled Release.

In The Last Decade

Junichi Enokizono

18 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junichi Enokizono Japan 12 335 291 155 152 54 20 667
Frida Ponthan United Kingdom 19 197 0.6× 606 2.1× 64 0.4× 28 0.2× 88 1.6× 33 1.1k
Toru Fuwa Japan 18 174 0.5× 444 1.5× 25 0.2× 119 0.8× 25 0.5× 32 745
Judit Cserepes Hungary 7 472 1.4× 416 1.4× 78 0.5× 17 0.1× 51 0.9× 10 786
Lela Buckingham United States 17 353 1.1× 505 1.7× 59 0.4× 27 0.2× 9 0.2× 48 983
Qiong Pan China 17 139 0.4× 528 1.8× 93 0.6× 17 0.1× 43 0.8× 61 943
E. Schlick United States 16 204 0.6× 312 1.1× 33 0.2× 66 0.4× 40 0.7× 51 968
C. Parmentier France 16 203 0.6× 206 0.7× 30 0.2× 70 0.5× 9 0.2× 33 760
Zhiling Li China 10 132 0.4× 255 0.9× 65 0.4× 14 0.1× 23 0.4× 25 726
Karobi Moitra United States 14 451 1.3× 411 1.4× 71 0.5× 10 0.1× 43 0.8× 20 791
Matthias Blumrich Germany 9 145 0.4× 239 0.8× 22 0.1× 61 0.4× 32 0.6× 12 496

Countries citing papers authored by Junichi Enokizono

Since Specialization
Citations

This map shows the geographic impact of Junichi Enokizono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Enokizono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Enokizono more than expected).

Fields of papers citing papers by Junichi Enokizono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Enokizono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Enokizono. The network helps show where Junichi Enokizono may publish in the future.

Co-authorship network of co-authors of Junichi Enokizono

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Enokizono. A scholar is included among the top collaborators of Junichi Enokizono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Enokizono. Junichi Enokizono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Enokizono, Junichi, et al.. (2025). A phase I study to evaluate the effect of high-dose carbidopa on levodopa pharmacokinetics. Frontiers in Pharmacology. 16. 1596139–1596139.
2.
3.
Hasegawa, Maki, Eri Taguchi, Takeshi Kuboyama, et al.. (2019). In vivo activation of PEGylated long circulating lipid nanoparticle to achieve efficient siRNA delivery and target gene knock down in solid tumors. Journal of Controlled Release. 311-312. 245–256. 33 indexed citations
4.
5.
Mukai, Hidefumi, Kentaro Hatanaka, Nobuhiro Yagi, et al.. (2018). Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis. Journal of Controlled Release. 294. 185–194. 23 indexed citations
6.
7.
Shinmi, Daisuke, et al.. (2017). Novel anticarcinoembryonic antigen antibody–drug conjugate has antitumor activity in the existence of soluble antigen. Cancer Medicine. 6(4). 798–808. 11 indexed citations
8.
Shinmi, Daisuke, et al.. (2016). One-Step Conjugation Method for Site-Specific Antibody–Drug Conjugates through Reactive Cysteine-Engineered Antibodies. Bioconjugate Chemistry. 27(5). 1324–1331. 58 indexed citations
9.
10.
Kasai, Noriyuki, et al.. (2012). Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancer.. PubMed. 4(4). 415–21. 12 indexed citations
11.
Enokizono, Junichi. (2009). Assessment of protein binding. Folia Pharmacologica Japonica. 134(2). 78–81.
12.
Enokizono, Junichi, Hiroyuki Kusuhara, Atsushi Ose, Alfred H. Schinkel, & Yuichi Sugiyama. (2008). Quantitative Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting Brain and Testis Penetration of Xenobiotic Compounds. Drug Metabolism and Disposition. 36(6). 995–1002. 116 indexed citations
13.
Enokizono, Junichi, Hiroyuki Kusuhara, & Yuichi Sugiyama. (2007). Regional Expression and Activity of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Mouse Intestine: Overlapping Distribution with Sulfotransferases. Drug Metabolism and Disposition. 35(6). 922–928. 53 indexed citations
14.
Hagihara, Koji, Hajime Kashima, Junichi Enokizono, et al.. (2007). Novel 4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)methylbenzofuran derivatives as selective α2C-adrenergic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(6). 1616–1621. 6 indexed citations
15.
Enokizono, Junichi, Hiroyuki Kusuhara, & Yuichi Sugiyama. (2007). Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens. Molecular Pharmacology. 72(4). 967–975. 149 indexed citations
16.
Enokizono, Junichi, Hiroyuki Kusuhara, & Yuichi Sugiyama. (2006). Involvement of Breast Cancer Resistance Protein (BCRP/ABCG2) in the Biliary Excretion and Intestinal Efflux of Troglitazone Sulfate, the Major Metabolite of Troglitazone with a Cholestatic Effect. Drug Metabolism and Disposition. 35(2). 209–214. 32 indexed citations
17.
Kato, Koichi, Catherine Sautès‐Fridman, Wakako Yamada, et al.. (2000). Structural basis of the interaction between IgG and fcγ receptors. Journal of Molecular Biology. 295(2). 213–224. 67 indexed citations
18.
Enokizono, Junichi, et al.. (2000). Effects of Calcium and Calcium Chelators on Growth and Morphology of Escherichia coli L-Form NC-7. Journal of Bacteriology. 182(5). 1419–1422. 56 indexed citations
19.
Hirayama, Kazuo, Naoyuki Yamada, Yoshiki Yamaguchi, et al.. (1998). Convenient Peptide Mapping of Immunoglobulin G2b and Differentiation between Leucine and Isoleucine Residues by Mass Spectrometry Using 2H-Labeled Leucine.. Journal of the Mass Spectrometry Society of Japan. 46(1). 83–89. 4 indexed citations
20.
Enokizono, Junichi, Mats Wikström, Ulf Sjöbring, et al.. (1997). NMR analysis of the interaction between protein L and Ig light chains. Journal of Molecular Biology. 270(1). 8–13. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frida Ponthan Breakdown of academic impact, for papers by Toru Fuwa Breakdown of academic impact, for papers by Judit Cserepes Breakdown of academic impact, for papers by Lela Buckingham Breakdown of academic impact, for papers by Qiong Pan Breakdown of academic impact, for papers by E. Schlick Breakdown of academic impact, for papers by C. Parmentier Breakdown of academic impact, for papers by Zhiling Li Breakdown of academic impact, for papers by Karobi Moitra Breakdown of academic impact, for papers by Matthias Blumrich
Rankless by CCL
2026